These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3947546)

  • 1. Primary thrombocythaemia treated with busulphan.
    Van de Pette JE; Prochazka AV; Pearson TC; Singh AK; Dickson ER; Wetherley-Mein G
    Br J Haematol; 1986 Feb; 62(2):229-37. PubMed ID: 3947546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial.
    Finazzi G; Ruggeri M; Rodeghiero F; Barbui T
    Br J Haematol; 2000 Sep; 110(3):577-83. PubMed ID: 10997967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocythaemia and multiple myeloma. A report on two cases.
    Selroos O; van Assendelft A
    Acta Med Scand; 1977; 201(3):243-7. PubMed ID: 557871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis.
    Passamonti F; Malabarba L; Orlandi E; Pascutto C; Brusamolino E; Astori C; Baratè C; Canevari A; Corso A; Bernasconi P; Cazzola M; Lazzarino M
    Br J Haematol; 2002 Mar; 116(4):855-61. PubMed ID: 11886392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
    Bergsagel DE; Messner H
    Br J Cancer; 1990 Jun; 61(6):895-8. PubMed ID: 2372493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet dysfunction in essential thrombocythaemia.
    Stathakis NE; Papayannis AG; Arapakis G; Gardikas C
    Ann Clin Res; 1974 Aug; 6(4):198-202. PubMed ID: 4473953
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of primary proliferative polycythaemia by venesection and low dose busulphan: retrospective study from one centre.
    Messinezy M; Pearson TC; Prochazka A; Wetherley-Mein G
    Br J Haematol; 1985 Dec; 61(4):657-66. PubMed ID: 4084455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Essential thrombocythemia: clinical and laboratory study of 6 cases].
    Grebe G; Alvo M; Lira P; Barria C; Mezzano D; Monsalve V
    Rev Med Chil; 1983 Dec; 111(12):1248-54. PubMed ID: 6687160
    [No Abstract]   [Full Text] [Related]  

  • 9. Essential thrombocythemia: a relative benign long-term course.
    Meisel S; Shpilberg O; Ramot B; Ben-Bassat I
    Isr J Med Sci; 1993 Apr; 29(4):190-4. PubMed ID: 8491569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dangers of surgery in uncontrolled haemorrhagic thrombocythaemia.
    Ravich RB; Gunz FW; Thompson IL; Reed CS
    Med J Aust; 1970 Apr; 1(14):704-8. PubMed ID: 5464014
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers.
    Barbui T; Finazzi G; Dupuy E; Kiladjian JJ; Brière J
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():149-60. PubMed ID: 8951786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
    Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
    Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of 51 Cr-labelled platelets and the chromosomal pattern in a case of primary haemorrhagic thrombocythaemia.
    Wiik AS; Paulson OB; Sorensen CM; Visfeldt J
    Acta Haematol; 1971; 46(3):177-87. PubMed ID: 5001521
    [No Abstract]   [Full Text] [Related]  

  • 14. Twenty-five year survival of chronic granulocytic leukaemia with spontaneous karyotype conversion.
    Singer CR; McDonald GA; Douglas AS
    Br J Haematol; 1984 Jun; 57(2):309-13. PubMed ID: 6587904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
    Kreft A; Büche G; Ghalibafian M; Buhr T; Fischer T; Kirkpatrick CJ
    Acta Haematol; 2005; 113(2):137-43. PubMed ID: 15802893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemia.
    Shvidel L; Sigler E; Haran M; Klepfish A; Duek A; Berrebi A; Shtalrid M
    Leukemia; 2007 Sep; 21(9):2071-2. PubMed ID: 17611572
    [No Abstract]   [Full Text] [Related]  

  • 17. [Essential thrombocythemia].
    Krupsky M; Berrebi A
    Harefuah; 1987 Mar; 112(6):268-72. PubMed ID: 3609955
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintenance therapy in the myeloproliferative disorders: the current options.
    Giles FJ
    Br J Haematol; 1991 Oct; 79 Suppl 1():92-5. PubMed ID: 1931719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.
    Palandri F; Catani L; Testoni N; Ottaviani E; Polverelli N; Fiacchini M; De Vivo A; Salmi F; Lucchesi A; Baccarani M; Vianelli N
    Am J Hematol; 2009 Apr; 84(4):215-20. PubMed ID: 19208420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anagrelide: a review of its use in the management of essential thrombocythaemia.
    Wagstaff AJ; Keating GM
    Drugs; 2006; 66(1):111-31. PubMed ID: 16398570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.